Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside

Bao, Xuhui; Liang, Yongjun; Chang, Hanman; Cai, Tianji; Feng, Baijie; Б. Гордон, К.; Zhu, Yuekun; Shi, Hailian; He, Yundong; Xie, Liyi

doi:10.1038/s41392-023-01690-3

Public

Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside

Published in Signal Transduction and Targeted Therapy • Jan 7, 2024

Authors:

Xuhui Bao

Yongjun Liang

Hanman Chang

Abstract

Proprotein convertase subtilisin/kexin type 9 (PCSK9) has evolved as a pivotal enzyme in lipid metabolism and a revolutionary therapeutic target for hypercholesterolemia and its related cardiovascular diseases (CVD). This comprehensive review delineates the intricate roles and wide-ranging implicati...

Subject

PCSK9

Kexin

Proprotein convertase

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!